FISCHER.NS
FISCHER · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for FISCHER.NS quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Certificate under SEBI (Depositories and Participants) Regulations, 2018
07 Jul 2026
Trading Window
29 Jun 2026
Copy of Newspaper Publication
26 Jun 2026
Clarification - Financial Results
25 Jun 2026
Outcome of Board Meeting
01 Jun 2026
Outcome of Board Meeting
30 May 2026
Monitoring Agency Report
16 May 2026
Copy of Newspaper Publication
15 May 2026
Press Release
14 May 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
09 Apr 2026
Disclosure under SEBI Takeover Regulations
08 Apr 2026
General Updates
31 Mar 2026
Trading Window
30 Mar 2026
Outcome of Board Meeting
24 Mar 2026
Trading Window
20 Mar 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Dividend - Rs 0.005 Per Share
Dividend - Rs 0.005 Per Share
Ex-date: 22 Sep 2025
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share
Ex-date: 12 Sep 2025
Board Meetings
29 May 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
29 May 2026
Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 29-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
30 Jan 2026
Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 30-Jan-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.
30 Jan 2026
To consider and approve the financial results for the period ended December 31, 2025
28 Oct 2025
Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 28-Oct-2025 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2025 and Other business.
28 Oct 2025
To consider and approve the financial results for the period ended September 30, 2025 and other business matters
14 Aug 2025
FISCHER MEDICAL VENTURES LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2025 and Other business.
14 Aug 2025
To consider and approve the unaudited financial results for the period ended Jun 30, 2025